Cytoxan Alternatives Compared
Cytoxan | Palbociclib | Keytruda |
|
---|
Cytoxan (cyclophosphamide) | Palbociclib | Keytruda (pembrolizumab) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Acute Lymphocytic Leukemia, Acute Nonlymphocytic Leukemia, Breast Cancer, Cancer, Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, Hodgkin's Lymphoma, Mantle Cell Lymphoma... View more |
Prescription only
Prescribed for Breast Cancer - Metastatic, Liposarcoma, Breast Cancer, Breast Cancer - Male. palbociclib may also be used for purposes not listed in this medication guide. |
Prescription only
Keytruda is an immunotherapy treatment called a checkpoint inhibitor that helps your immune system fight cancer and is used to treat many different types of cancer in adults and children including... View more |
||||||||
More about Cytoxan (cyclophosphamide) | More about Palbociclib | More about Keytruda (pembrolizumab) | ||||||||
Ratings & Reviews | ||||||||||
Cytoxan has an average rating of 9.8 out of 10 from a total of 7 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Palbociclib has an average rating of 6.9 out of 10 from a total of 98 ratings on Drugs.com. 63% of reviewers reported a positive effect, while 29% reported a negative effect. |
Keytruda has an average rating of 4.4 out of 10 from a total of 216 ratings on Drugs.com. 35% of reviewers reported a positive effect, while 57% reported a negative effect. |
||||||||
Drug Class | ||||||||||
Side Effects | ||||||||||
See also: Cytoxan side effects in more detail. |
See also: palbociclib side effects in more detail. |
See also: Keytruda side effects in more detail. |
||||||||
Generic Availability | ||||||||||
N/A |
N/A |
|||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Keytruda prices |
||||||||
Dosage Forms Available | ||||||||||
N/A |
N/A |
|
||||||||
Brand Names | ||||||||||
N/A |
Ibrance |
N/A |
||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
6.5 hours |
29 hours |
624 hours |
||||||||
CSA Schedule ** View glossary of terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 381 drugs are known to interact with Cytoxan:
|
A total of 459 drugs are known to interact with palbociclib:
|
A total of 16 drugs are known to interact with Keytruda:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | ||||||||||
First Approval Date | ||||||||||
November 16, 1959 |
N/A |
N/A |
||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||
N/A |
N/A |
N/A |
||||||||
More Information | ||||||||||
Patient resources | ||||||||||
Professional Resources | ||||||||||
Related Treatment Guide | ||||||||||
|
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.